CERo Therapeutics Holdings IncNASDAQ:CERO
- LAST PRICE1.3700
- TODAY'S CHANGE (%)-0.0400 (-2.8369%)
- Bid / Lots1.3200/ 7
- Ask / Lots1.4300/ 5
- Open / Previous Close1.4200 / 1.4100
- Day Range
- 52 Week Range
- Volume94,318
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CERO |
|---|---|---|
| 09:32 ET | 3873 | 1.4301 |
| 09:36 ET | 1935 | 1.41 |
| 09:50 ET | 1000 | 1.4326 |
| 09:52 ET | 100 | 1.43 |
| 09:54 ET | 200 | 1.4328 |
| 10:03 ET | 916 | 1.44 |
| 10:06 ET | 6703 | 1.43 |
| 10:14 ET | 2500 | 1.4699 |
| 10:15 ET | 170 | 1.455 |
| 10:17 ET | 500 | 1.45 |
| 10:26 ET | 100 | 1.44 |
| 10:28 ET | 1000 | 1.44 |
| 10:33 ET | 2500 | 1.4101 |
| 11:22 ET | 741 | 1.4201 |
| 11:29 ET | 176 | 1.435 |
| 11:33 ET | 300 | 1.4223 |
| 11:36 ET | 924 | 1.435 |
| 11:45 ET | 175 | 1.41 |
| 11:47 ET | 3000 | 1.4399 |
| 11:49 ET | 124 | 1.425 |
| 11:58 ET | 100 | 1.43 |
| 12:00 ET | 175 | 1.43 |
| 12:03 ET | 490 | 1.41 |
| 12:20 ET | 356 | 1.43 |
| 12:32 ET | 2027 | 1.4101 |
| 12:54 ET | 621 | 1.41 |
| 01:10 ET | 500 | 1.42 |
| 01:15 ET | 1279 | 1.42 |
| 01:24 ET | 100 | 1.41 |
| 01:32 ET | 100 | 1.42 |
| 01:37 ET | 2900 | 1.4 |
| 01:42 ET | 2335 | 1.3996 |
| 01:44 ET | 200 | 1.4001 |
| 01:50 ET | 200 | 1.3996 |
| 02:08 ET | 142 | 1.3897 |
| 02:09 ET | 200 | 1.38 |
| 02:11 ET | 250 | 1.3889 |
| 02:13 ET | 100 | 1.38 |
| 02:27 ET | 500 | 1.39 |
| 02:29 ET | 385 | 1.38 |
| 02:38 ET | 150 | 1.37 |
| 02:54 ET | 3900 | 1.3899 |
| 02:56 ET | 400 | 1.3895 |
| 03:02 ET | 237 | 1.3806 |
| 03:05 ET | 600 | 1.39 |
| 03:12 ET | 1000 | 1.3899 |
| 03:14 ET | 1150 | 1.383 |
| 03:20 ET | 539 | 1.38 |
| 03:21 ET | 310 | 1.37 |
| 03:23 ET | 1000 | 1.3899 |
| 03:34 ET | 300 | 1.3701 |
| 03:36 ET | 100 | 1.38 |
| 03:39 ET | 583 | 1.38 |
| 03:43 ET | 100 | 1.39 |
| 03:48 ET | 100 | 1.39 |
| 03:52 ET | 3000 | 1.39 |
| 03:56 ET | 1100 | 1.3833 |
| 03:57 ET | 100 | 1.39 |
| 03:59 ET | 1824 | 1.37 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CERo Therapeutics Holdings Inc | 20.2M | -3.6x | --- |
Protext Mobility Inc | 20.2M | 0.0x | --- |
Aptose Biosciences Inc | 19.6M | -0.2x | --- |
Bioxytran Inc | 21.0M | -4.0x | --- |
RenovoRx Inc | 21.0M | -1.2x | --- |
Biomx Inc | 19.3M | -0.6x | --- |
Company Information
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.
Contact Information
- Headquarters
- 201 Haskins Way, Suite 230SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 215-731-9450
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Brian Atwood
- President
- Douglas Fisher
- Chief Executive Officer, Director
- Christopher Ehrlich
- Chief Financial Officer
- Daniel Geffken
- Independent Director
- Barbara Kosacz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 14.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.38 |
Book Value | $-0.92 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
